Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC.

标题
Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 37, Issue 4_suppl, Pages 185-185
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2019-01-30
DOI
10.1200/jco.2019.37.4_suppl.185

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search